Literature DB >> 30894474

Antibody-Induced Internalization of HIV-1 Env Proteins Limits Surface Expression of the Closed Conformation of Env.

Sai Priya Anand1,2, Jonathan R Grover3, William D Tolbert4, Jérémie Prévost1,5, Jonathan Richard1, Shilei Ding1,5, Sophie Baril1, Halima Medjahed1, David T Evans6,7, Marzena Pazgier4, Walther Mothes3, Andrés Finzi8,2,5.   

Abstract

To minimize immune responses against infected cells, HIV-1 limits the surface expression of its envelope glycoprotein (Env). Here, we demonstrate that this mechanism is specific for the Env conformation and affects the efficiency of antibody-dependent cellular cytotoxicity (ADCC). Using flow cytometry and confocal microscopy, we show that broadly neutralizing antibodies (bNAbs) targeting the "closed" conformation of Env induce its internalization from the surface. In contrast, non-neutralizing antibodies (nNAbs) are displayed on the cell surface for prolonged period of times. The bNAb-induced Env internalization can be decreased by blocking dynamin function, which translates into higher susceptibilities of infected cells to ADCC. Our results suggest that antibody-mediated Env internalization is a mechanism used by HIV-1 to evade immune responses against the "closed" conformation of Env expressed on HIV-1-infected cells.IMPORTANCE HIV-1 has evolved to acquire several strategies to limit the exposure of its envelope glycoproteins (Env) on the surface of infected cells. In this study, we show that antibody-induced Env internalization is conformation specific and reduces the susceptibility of infected cells to antibody-dependent cellular cytotoxicity (ADCC). Thus, a better understanding of this mechanism might help develop antibodies with improved capacities to mediate ADCC.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  ADCC; Env; Env conformation; HIV-1; Internalization; bNAbs; dynamin; nonneutralizing antibodies

Mesh:

Substances:

Year:  2019        PMID: 30894474      PMCID: PMC6532100          DOI: 10.1128/JVI.00293-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  64 in total

1.  A single amino acid change in the cytoplasmic domains of measles virus glycoproteins H and F alters targeting, endocytosis, and cell fusion in polarized Madin-Darby canine kidney cells.

Authors:  M Moll; H D Klenk; G Herrler; A Maisner
Journal:  J Biol Chem       Date:  2001-02-28       Impact factor: 5.157

2.  Endocytosis of the Nipah virus glycoproteins.

Authors:  Carola Vogt; Markus Eickmann; Sandra Diederich; Markus Moll; Andrea Maisner
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

3.  In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail.

Authors:  P N Fultz; P J Vance; M J Endres; B Tao; J D Dvorin; I C Davis; J D Lifson; D C Montefiori; M Marsh; M H Malim; J A Hoxie
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients.

Authors:  D N Forthal; G Landucci; R Haubrich; B Keenan; B D Kuppermann; J G Tilles; J Kaplan
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

5.  Absence of viral antigens on the surface of equine herpesvirus-1-infected peripheral blood mononuclear cells: a strategy to avoid complement-mediated lysis.

Authors:  Karen M van der Meulen; Hans J Nauwynck; Maurice B Pensaert
Journal:  J Gen Virol       Date:  2003-01       Impact factor: 3.891

6.  Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain.

Authors:  Zhigao Bu; Ling Ye; Andrei Vzorov; Dahnide Taylor; Richard W Compans; Chinglai Yang
Journal:  Virology       Date:  2004-10-10       Impact factor: 3.616

7.  Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for env incorporation into virions and infectivity.

Authors:  Guillaume Blot; Katy Janvier; Sophie Le Panse; Richard Benarous; Clarisse Berlioz-Torrent
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.

Authors:  Daniel A Calarese; Christopher N Scanlan; Michael B Zwick; Songpon Deechongkit; Yusuke Mimura; Renate Kunert; Ping Zhu; Mark R Wormald; Robyn L Stanfield; Kenneth H Roux; Jeffery W Kelly; Pauline M Rudd; Raymond A Dwek; Hermann Katinger; Dennis R Burton; Ian A Wilson
Journal:  Science       Date:  2003-06-27       Impact factor: 47.728

9.  Antibody-induced internalization of viral glycoproteins and gE-gI Fc receptor activity protect pseudorabies virus-infected monocytes from efficient complement-mediated lysis.

Authors:  Gerlinde R Van de Walle; Herman W Favoreel; Hans J Nauwynck; Maurice B Pensaert
Journal:  J Gen Virol       Date:  2003-04       Impact factor: 3.891

10.  A visual screen of a GFP-fusion library identifies a new type of nuclear envelope membrane protein.

Authors:  M M Rolls; P A Stein; S S Taylor; E Ha; F McKeon; T A Rapoport
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

View more
  22 in total

1.  Elucidating the Basis for Permissivity of the MT-4 T-Cell Line to Replication of an HIV-1 Mutant Lacking the gp41 Cytoplasmic Tail.

Authors:  Melissa V Fernandez; Huxley K Hoffman; Nairi Pezeshkian; Philip R Tedbury; Schuyler B van Engelenburg; Eric O Freed
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

Review 2.  Antibody-mediated complement activation in pathology and protection.

Authors:  Benjamin S Goldberg; Margaret E Ackerman
Journal:  Immunol Cell Biol       Date:  2020-04-06       Impact factor: 5.126

Review 3.  The Conformational States of the HIV-1 Envelope Glycoproteins.

Authors:  Qian Wang; Andrés Finzi; Joseph Sodroski
Journal:  Trends Microbiol       Date:  2020-05-14       Impact factor: 17.079

4.  Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.

Authors:  Shijian Zhang; Hanh T Nguyen; Haitao Ding; Jia Wang; Shitao Zou; Lihong Liu; Debjani Guha; Dana Gabuzda; David D Ho; John C Kappes; Joseph Sodroski
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

5.  HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses.

Authors:  Kiera L Clayton; Geetha Mylvaganam; Alonso Villasmil-Ocando; Heather Stuart; Marcela V Maus; Mohammad Rashidian; Hidde L Ploegh; Bruce D Walker
Journal:  Cell Host Microbe       Date:  2021-02-10       Impact factor: 21.023

6.  Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells.

Authors:  Evan D Rossignol; Anne-Sophie Dugast; Hacheming Compere; Christopher A Cottrell; Jeffrey Copps; Shu Lin; Deniz Cizmeci; Michael S Seaman; Margaret E Ackerman; Andrew B Ward; Galit Alter; Boris Julg
Journal:  Cell Rep       Date:  2021-05-25       Impact factor: 9.423

7.  Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir.

Authors:  Jyothi K Rajashekar; Jonathan Richard; Jagadish Beloor; Jérémie Prévost; Sai Priya Anand; Guillaume Beaudoin-Bussières; Liang Shan; Dietmar Herndler-Brandstetter; Gabrielle Gendron-Lepage; Halima Medjahed; Catherine Bourassa; Fleur Gaudette; Irfan Ullah; Kelly Symmes; Andrew Peric; Emily Lindemuth; Frederic Bibollet-Ruche; Jun Park; Hung-Ching Chen; Daniel E Kaufmann; Beatrice H Hahn; Joseph Sodroski; Marzena Pazgier; Richard A Flavell; Amos B Smith; Andrés Finzi; Priti Kumar
Journal:  Cell Host Microbe       Date:  2021-05-20       Impact factor: 31.316

8.  The HIV-1 Env gp120 Inner Domain Shapes the Phe43 Cavity and the CD4 Binding Site.

Authors:  Jérémie Prévost; William D Tolbert; Halima Medjahed; Rebekah T Sherburn; Navid Madani; Daria Zoubchenok; Gabrielle Gendron-Lepage; Althea E Gaffney; Melissa C Grenier; Sharon Kirk; Natasha Vergara; Changze Han; Brendan T Mann; Agnès L Chénine; Adel Ahmed; Irwin Chaiken; Frank Kirchhoff; Beatrice H Hahn; Hillel Haim; Cameron F Abrams; Amos B Smith; Joseph Sodroski; Marzena Pazgier; Andrés Finzi
Journal:  mBio       Date:  2020-05-26       Impact factor: 7.867

9.  Immune Correlates of Disease Progression in Linked HIV-1 Infection.

Authors:  Michael Tuen; Jude S Bimela; Andrew N Banin; Shilei Ding; Gordon W Harkins; Svenja Weiss; Vincenza Itri; Allison R Durham; Stephen F Porcella; Sonal Soni; Luzia Mayr; Josephine Meli; Judith N Torimiro; Marcel Tongo; Xiaohong Wang; Xiang-Peng Kong; Arthur Nádas; Daniel E Kaufmann; Zabrina L Brumme; Aubin J Nanfack; Thomas C Quinn; Susan Zolla-Pazner; Andrew D Redd; Andrés Finzi; Miroslaw K Gorny; Phillipe N Nyambi; Ralf Duerr
Journal:  Front Immunol       Date:  2019-05-14       Impact factor: 7.561

Review 10.  Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure.

Authors:  Jeffrey C Umotoy; Steven W de Taeye
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.